S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:PMVP

PMV Pharmaceuticals (PMVP) Stock Price, News & Analysis

$1.70
+0.05 (+3.03%)
(As of 03/28/2024 ET)
Today's Range
$1.64
$1.71
50-Day Range
$1.51
$1.93
52-Week Range
$1.18
$9.72
Volume
643,441 shs
Average Volume
715,173 shs
Market Capitalization
$87.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

PMV Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
252.9% Upside
$6.00 Price Target
Short Interest
Bearish
5.56% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of PMV Pharmaceuticals in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($1.47) to ($1.64) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.13 out of 5 stars

Medical Sector

593rd out of 939 stocks

Pharmaceutical Preparations Industry

282nd out of 444 stocks

PMVP stock logo

About PMV Pharmaceuticals Stock (NASDAQ:PMVP)

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

PMVP Stock Price History

PMVP Stock News Headlines

Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
PMVP Apr 2024 5.000 call
Oppenheimer Keeps Their Hold Rating on PMV Pharmaceuticals (PMVP)
Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
TD Cowen Reaffirms Their Buy Rating on PMV Pharmaceuticals (PMVP)
See More Headlines
Receive PMVP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/29/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PMVP
Fax
N/A
Employees
63
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.00
High Stock Price Target
$7.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+252.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-68,960,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.41 per share

Miscellaneous

Free Float
47,533,000
Market Cap
$87.45 million
Optionable
Optionable
Beta
1.66
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. David H. Mack Ph.D. (Age 62)
    Co-Founder, CEO, President & Director
    Comp: $762.02k
  • Dr. Arnold J. Levine Ph.D. (Age 84)
    Co-Founder, Director & Member of Scientific Advisory Board
    Comp: $140k
  • Mr. Winston Kung M.B.A.Mr. Winston Kung M.B.A. (Age 48)
    Advisor
    Comp: $591.29k
  • Dr. Leila Alland M.D. (Age 61)
    Advisor
    Comp: $601.93k
  • Dr. Thomas E. Shenk Ph.D. (Age 77)
    Co-Founder & Member of Scientific Advisory Board
  • Mr. Michael Carulli
    Chief Financial Officer
  • Mr. Robert Ticktin (Age 62)
    General Counsel, Head of Operations & Company Secretary
  • Mr. Tim Smith
    Senior VP & Head of Corporate Development and Investor Relations
  • Ms. Crystal Zuckerman
    Vice President of Human Resources
  • Dr. Binh Vu Ph.D.
    Senior VP of Drug Discovery & CMC

PMVP Stock Analysis - Frequently Asked Questions

Should I buy or sell PMV Pharmaceuticals stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PMV Pharmaceuticals in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PMVP shares.
View PMVP analyst ratings
or view top-rated stocks.

What is PMV Pharmaceuticals' stock price target for 2024?

2 analysts have issued 1 year price objectives for PMV Pharmaceuticals' shares. Their PMVP share price targets range from $5.00 to $7.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 252.9% from the stock's current price.
View analysts price targets for PMVP
or view top-rated stocks among Wall Street analysts.

How have PMVP shares performed in 2024?

PMV Pharmaceuticals' stock was trading at $3.10 at the beginning of 2024. Since then, PMVP stock has decreased by 45.2% and is now trading at $1.70.
View the best growth stocks for 2024 here
.

When is PMV Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our PMVP earnings forecast
.

How were PMV Pharmaceuticals' earnings last quarter?

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) issued its quarterly earnings results on Thursday, February, 29th. The company reported ($0.31) earnings per share for the quarter, beating the consensus estimate of ($0.39) by $0.08.

What ETFs hold PMV Pharmaceuticals' stock?

ETFs with the largest weight of PMV Pharmaceuticals (NASDAQ:PMVP) stock in their portfolio include Virtus LifeSci Biotech Clinical Trials ETF (BBC).IQ Chaikin U.S. Small Cap ETF (CSML).

What other stocks do shareholders of PMV Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PMV Pharmaceuticals investors own include Vical (VICL), Arista Networks (ANET), Apollo Medical (AMEH), Advanced Micro Devices (AMD), Ambarella (AMBA), Alexion Pharmaceuticals (ALXN), Akoustis Technologies (AKTS), Agios Pharmaceuticals (AGIO), Admiral Group (ADM) and Adobe (ADBE).

When did PMV Pharmaceuticals IPO?

PMV Pharmaceuticals (PMVP) raised $126 million in an initial public offering on Friday, September 25th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, BofA Securities, Cowen and Evercore ISI served as the underwriters for the IPO.

Who are PMV Pharmaceuticals' major shareholders?

PMV Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (4.70%), Vanguard Group Inc. (4.68%), Verition Fund Management LLC (3.09%), PFM Health Sciences LP (2.88%), Goldman Sachs Group Inc. (1.57%) and Goldman Sachs Group Inc. (1.57%). Insiders that own company stock include Arnold J Levine, Arnold J Levine, David Henry Mack, Deepika Jalota, Euclidean Capital Llc, Laszlo Kopits, Leila Alland, Ling Zang, Orbimed Advisors Llc, Paul Klauder, Richard A Heyman, Thilo Schroeder and Winston Kung.
View institutional ownership trends
.

How do I buy shares of PMV Pharmaceuticals?

Shares of PMVP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PMVP) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners